251 | 9717829 | Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. | Clin Cancer Res | 1998 Aug |
1 |
252 | 9719461 | p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. | Cancer Lett | 1998 Jul 17 |
11 |
253 | 9731488 | High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele. | Cancer Res | 1998 Sep 1 |
4 |
254 | 9731495 | Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues. | Cancer Res | 1998 Sep 1 |
1 |
255 | 9738462 | p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment. | FEBS Lett | 1998 Aug 28 |
2 |
256 | 9751125 | Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. | Cell Growth Differ | 1998 Sep |
3 |
257 | 9780227 | Butylated hydroxytoluene modulates DNA methylation in rats. | Eur J Biochem | 1998 Sep 15 |
1 |
258 | 9795126 | Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells. | Brain Res Mol Brain Res | 1998 Nov 12 |
1 |
259 | 9796694 | Inhibition of p53-dependent apoptosis by the KIT tyrosine kinase: regulation of mitochondrial permeability transition and reactive oxygen species generation. | Oncogene | 1998 Oct 1 |
4 |
260 | 9808574 | Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. | Blood | 1998 Nov 15 |
1 |
261 | 9816169 | Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint. | Clin Cancer Res | 1996 Feb |
4 |
262 | 9834241 | CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents. | Blood | 1998 Dec 1 |
1 |
263 | 9839726 | Kainic acid-induced neuronal loss and glial changes in the hippocampal CA3 of p53-deficient mouse. | Neurosci Lett | 1998 Oct 9 |
1 |
264 | 9840938 | Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity. | Oncogene | 1998 Nov 26 |
1 |
265 | 9843859 | Alveolar macrophage apoptosis and TNF-alpha, but not p53, expression correlate with murine response to bleomycin. | Am J Physiol | 1998 Dec |
1 |
266 | 9849426 | p53 expression in skin carcinogenesis and its relationship to cell proliferation and tumour growth. | Eur J Cancer | 1998 Aug |
4 |
267 | 9850078 | Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis. | Cancer Res | 1998 Dec 1 |
2 |
268 | 9850079 | The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. | Cancer Res | 1998 Dec 1 |
7 |
269 | 9851850 | p53-mediated germ cell quality control in spermatogenesis. | Dev Biol | 1998 Dec 1 |
1 |
270 | 9856857 | Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. | J Neurosci Res | 1998 Dec 15 |
1 |
271 | 9858902 | p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments. | Anticancer Res | 1998 Sep-Oct |
1 |
272 | 9872997 | Cellular protection mechanisms against extracellular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. | J Biol Chem | 1999 Jan 8 |
1 |
273 | 9880587 | A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. | J Neurosci | 1999 Jan 15 |
1 |
274 | 9892179 | Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts. | Cancer Res | 1999 Jan 1 |
1 |
275 | 10022227 | Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. | Toxicol Lett | 1998 Dec 28 |
4 |
276 | 10081609 | The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. | Cell Mol Neurobiol | 1999 Apr |
5 |
277 | 10082513 | Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. | Mol Cell Biol | 1999 Apr |
3 |
278 | 10094408 | Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable. | Mol Cell Biochem | 1999 Jan |
5 |
279 | 10096421 | Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine. | Cancer Lett | 1999 Jan 29 |
1 |
280 | 10098976 | Growing and differentiating characterization of aortic smooth muscle cell line, p53LMAC01 obtained from p53 knock out mice. | Mol Cell Biochem | 1999 Jan |
2 |
281 | 10187847 | Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. | J Biol Chem | 1999 Apr 9 |
2 |
282 | 10200338 | Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells. | Int J Oncol | 1999 May |
2 |
283 | 10200488 | Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance. | Cell Death Differ | 1998 May |
1 |
284 | 10222137 | An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. | Exp Cell Res | 1999 May 1 |
1 |
285 | 10223204 | LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. | Carcinogenesis | 1999 Apr |
2 |
286 | 10223621 | Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells. | Oncol Res | 1998 |
4 |
287 | 10226577 | p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines. | Anticancer Res | 1999 Jan-Feb |
4 |
288 | 10321741 | Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties. | Oncogene | 1999 Mar 25 |
1 |
289 | 10339661 | Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. | Int J Oncol | 1999 Jun |
1 |
290 | 10354508 | The relationship of p53 and stress proteins in response to bleomycin and retinoic acid in the p53 heterozygous mouse. | Biochim Biophys Acta | 1999 Jun 8 |
6 |
291 | 10358069 | DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. | J Biol Chem | 1999 Jun 11 |
1 |
292 | 10359011 | p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. | Cell Growth Differ | 1999 May |
3 |
293 | 10373675 | Tissue-specific expression of the p53 tumor-suppressor gene in the intestine of transgenic mice exposed to DMH and p53 antibodies. | Oncol Rep | 1999 Jul-Aug |
3 |
294 | 10395176 | Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity. | Cancer Lett | 1999 May 24 |
1 |
295 | 10403253 | DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. | Nature | 1999 Jul 1 |
1 |
296 | 10404639 | Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin. | Int J Biochem Cell Biol | 1999 Jun |
12 |
297 | 10425208 | The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. | Biochem Biophys Res Commun | 1999 Aug 2 |
3 |
298 | 10432310 | Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. | Biochem J | 1999 Aug 15 |
2 |
299 | 10435582 | Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. | Immunity | 1999 Jul |
1 |
300 | 10435642 | Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1). | Oncogene | 1999 Jul 22 |
2 |